Search results for: NICE
Filter search results
Katherine Payne
30 January 2024
…UK Academic Fellowship in Health Economics to focus on the evaluation and valuation of genomic technologies including genomic-based diagnostics and pharmacogenetic tests. Katherine was a member of a NICE Technology…
Prof. John Cairns
8 March 2024
Professor John Cairns is a Professor of Health Economics at the London School of Hygiene and tropical Medicine. Professor Cairns has been a member of the NICE diagnostics advisory committee…
OHE’s contribution to health economics
1 May 2023
…a consistent flow of really nice studies Professor Paul Nightingale, Associate Dean of Research at the University of Sussex Business School “Within SPRU, we’ve always been interested in, enjoyed and…
How Have HTA Agencies Evolved Their Methods Over Time?
29 April 2024
Share this: Download publication Priscila Radu Gayathri Kumar Patricia Cubi-Molla Martina Garau Eleanor Bell Jia Pan Ramiro Gilardino Julie Van Bavel Agnes Brandtmüller Katherine Nelson Melinda Goodall The many changes…
Using Target Product Profiles (TPPs) to improve diagnostic testing for cancer
10 June 2024
…the final decision-maker (NICE and the NHS), early economic evaluation can help to estimate what characteristics the diagnostic must have in order to achieve a favourable decision outcome in terms…
OHE at ISPOR Europe 2024
17 November 2024, 8:00am
…Regulatory Environments Lotte Steuten (discussion leader) 17:00-18:00 Workshop Is NICE Too Severe With Severity? Exploring How Well Its Severity Modifier Aligns With UK Preferences Helen Hayes & Chris Skedgal 16:00-19:00…
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS England, NICE, the University of Manchester, and Bangor University….
Educational programmes
…systems allocate scarce resources, and how evidence is interpreted, from NICE’s benchmark values to emerging global approaches. Guided by leading OHE economists and international experts, this session cuts through the…
From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics
21 July 2025
…antimicrobials – Spectrum, Transmission, Enablement, Diversity, and Insurance value. The STEDI-framework ultimately formed the basis of the NICE-NHS England subscription model for evaluating and purchasing antimicrobials in the UK. The…